Key result
Mixed PEG liposomes increase antitumor activity versus single PEG modifications by enhancing doxorubicin tumor distribution.
Mixed PEG-DSG modified liposomes optimize fixed aqueous layer thickness and improve the targeted delivery and antitumor efficacy of doxorubicin.
Does not support clinical adoption of mixed-PEG liposomes; leaves open translation of enhanced tumor delivery from animal models.
It is known that polyethyleneglycol (PEG) modification of the liposome surface leads to the formation of a fixed aqueous layer around the liposomes due to interaction between the PEG polymer and water molecules, which prevents the attraction of opsonins. When a combination of PEG-distearolyglycerol (PEG-DSG) whose characteristics are remarkably different is used, interaction between molecules occurs, leading to increased fixed aqueous layer thickness (FALT). From this speculation, we studied the effect of both modification of PEG900-DSG and PEG2000-DSG modified liposome on FALT, cell uptake and biodistribution. The FALT of mixed PEG modified liposome increased, compared to that of each single PEG modified liposome. In this mixed modification, maximum FALT was shown at liposome modified by added PEG-2000:PEG-900=2:1. This most suitable additional ratio was equal to actual incorporated ratio. On the other hand, cell uptake of mixed modified liposome containing doxorubicin (DOX) was similar with that of PEG2000 modified liposome. Furthermore, mixed PEG modification of liposome was tendency to increase cytotoxicity, compared to that of other modifications. After DOX contained liposome treatment, DOX distribution in the tumor and antitumor activity of DOX increase by mixed PEG modification. In conclusion, it was suggested that mixed PEG liposome (PEG-2000:PEG-900=2:1) was useful for cancer chemotherapy.
No takes yet. Share an insight, caveat, or question.
Sadzuka et al. (2005) studied Cancer. Mixed PEG-DSG modified liposomes (PEG-2000/PEG-900=2/1) vs. Single PEG modified liposomes was evaluated on Fixed aqueous layer thickness (FALT) and antitumor activity. Mixed PEG modification of liposomes (PEG-2000/PEG-900=2/1) increased the fixed aqueous layer thickness, enhanced doxorubicin distribution in tumors, and increased antitumor activity compared to single PEG modifications.
Synapse has enriched one closely related paper. Consider it for comparative context: